(Q35570097)

8 August 2017

1 reference

title

Upper respiratory tract immunity (English)

1 reference

8 August 2017

Upper Respiratory Tract Immunity (English)

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

26 March 2024

main subject

mucosal immune system

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583144

26 March 2024

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

26 March 2024

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

26 March 2024

author name string

Adrian W. Zuercher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583144

26 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14583144

26 March 2024

publication date

1 January 2003

1 reference

full work available at URL

8 August 2017

https://www.liebertpub.com/doi/pdf/10.1089/088282403322396091

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

26 March 2024

1 reference

8 August 2017

volume

16

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

279-289

1 reference

Kinetics of the mucosal antibody secreting cell response and evidence of specific lymphocyte migration to the lung after oral immunisation with attenuated S. enterica var. typhimurium

8 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration

26 March 2024

2

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions

26 March 2024

3

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Trachea, lung, and tracheobronchial lymph nodes are the major sites where antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles.

26 March 2024

4

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

26 March 2024

Developmental Biology

5

104

159

Barnfield C.

2000

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

26 March 2024

6

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

26 March 2024

7

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.

26 March 2024

8

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells

26 March 2024

11

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Regional specialization in the mucosal immune system: what happens in the microcompartments?

26 March 2024

12

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Regionalized immune function of tonsils and adenoids

26 March 2024

13

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Nasal-associated lymphoid tissue is an inductive site for rat tear IgA antibody responses.

26 March 2024

14

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.

26 March 2024

15

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

26 March 2024

16

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease

26 March 2024

17

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Induction of intestinal rotavirus-specific antibodies in respiratory, but not gut, lymphoid tissues following mucosal immunization of mice with inactivated rotavirus

26 March 2024

19

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes

26 March 2024

20

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Nasal immunization of mice with virus-like particles protects offspring against rotavirus diarrhea

26 March 2024

21

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication.

26 March 2024

22

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Peyer's patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit

26 March 2024

23

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Cutting edge: dichotomy of homing receptor dependence by mucosal effector B cells: alpha(E) versus L-selectin

26 March 2024

24

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Absence of L-selectin delays mucosal B cell responses in nonintestinal effector tissues

26 March 2024

25

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Mucosal addressin expression and binding-interactions with naive lymphocytes vary among the cranial, oral, and nasal-associated lymphoid tissues

26 March 2024

26

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

26 March 2024

Nasal vaccines

28

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Initiation of NALT organogenesis is independent of the IL-7R, LTbetaR, and NIK signaling pathways but requires the Id2 gene and CD3(-)CD4(+)CD45(+) cells

26 March 2024

30

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B.

26 March 2024

31

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus

26 March 2024

32

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract

26 March 2024

33

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant

26 March 2024

34

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

BBG2Na an RSV subunit vaccine candidate intramuscularly injected to human confers protection against viral challenge after nasal immunization in mice

26 March 2024

36

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Mucosal [SIgA] and serum [IgG] immunologic responses in the community after a single intra-nasal immunization with a new inactivated trivalent influenza vaccine

26 March 2024

37

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Cutting edge: organogenesis of nasal-associated lymphoid tissue (NALT) occurs independently of lymphotoxin-alpha (LT alpha) and retinoic acid receptor-related orphan receptor-gamma, but the organization of NALT is LT alpha dependent

26 March 2024

38

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Comparison of murine nasal-associated lymphoid tissue and Peyer's patches

26 March 2024

39

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Nasal immune system: distinctive Th0 and Th1/Th2 type environments in murine nasal-associated lymphoid tissues and nasal passage, respectively

26 March 2024

40

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one.

26 March 2024

41

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Glycoconjugate expression in follicle-associated epithelium (FAE) covering the nasal-associated lymphoid tissue (NALT) in specific pathogen-free and conventional rats

26 March 2024

42

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults

26 March 2024

43

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity

26 March 2024

44

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Chemokines and the tissue-specific migration of lymphocytes

26 March 2024

45

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

The role of nasopharyngeal lymphoid tissue

26 March 2024

46

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Can needle-free administration of vaccines become the norm in global immunization?

26 March 2024

47

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice

26 March 2024

48

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Preferential localization of effector memory cells in nonlymphoid tissue

26 March 2024

49

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Cytokine mRNAs in the nasal-associated lymphoid tissue during influenza virus infection and nasal vaccination

26 March 2024

50

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants

26 March 2024

53

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Critical Reviews in Immunology

26 March 2024

54

21

103

McCluskie M.J.

2001

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Is BALT a major component of the human lung immune system?

26 March 2024

56

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice

26 March 2024

57

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues

26 March 2024

58

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults

26 March 2024

59

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Humoral and cellular immune responses in the murine respiratory tract following oral immunization with cholera toxin or Escherichia coli heat-labile enterotoxin

26 March 2024

61

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Strategies of immunization against mucosal infections.

26 March 2024

65

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit

26 March 2024

66

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

26 March 2024

67

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Isotype-specific selection of high affinity memory B cells in nasal-associated lymphoid tissue

26 March 2024

69

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung

26 March 2024

71

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Lectin binding patterns in rat nasal-associated lymphoid tissue (NALT) and the influence of various types of lectin on particle uptake in NALT

26 March 2024

72

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection

26 March 2024

73

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Optimal induction of upper respiratory tract immunity to reovirus 1/L by combined upper and lower respiratory tract inoculation

26 March 2024

74

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-gamma production and local IgA response

26 March 2024

75

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

26 March 2024

76

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection

26 March 2024

79

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue

26 March 2024

80

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Nasal lymphoid tissue (NALT) as a mucosal immune inductive site

26 March 2024

81

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Generation of female genital tract antibody responses by local or central (common) mucosal immunization

26 March 2024

82

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses

26 March 2024

83

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Distinct mechanisms for cross-protection of the upper versus lower respiratory tract through intestinal priming

26 March 2024

84

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

Structural and functional differences between putative mucosal inductive sites of the rat

26 March 2024

85

1 reference

https://api.crossref.org/works/10.1089/088282403322396091

26 March 2024

Identifiers

1 reference

8 August 2017

1 reference